Emerald, Forma Strike Deal

Xconomy Seattle — 

Emerald Biostructures, the Bainbridge Island, WA-based company that produces X-ray crystallography images of drug targets, said today it has formed a partnership with Cambridge, MA-based Forma Therapeutics. The multi-year deal covers multiple targets for cancer drugs that Forma is seeking to develop. Financial terms of the deal aren’t being disclosed, although it will provide salaries for multiple full-time employees at Emerald. I wrote last month about how Emerald escaped a potential bankruptcy with the help of Forma and some venture capitalists in Boston.